Respectfully disagree. The ~15% (US) and <10% (WW) numbers I posted in this thread are pot'l %reductions in Mavyret's addressable mkt—not %reductions in ACTUAL SALES. If we presume that Mavyret wouldve gotten ~50% of ESRX biz, then %reduction in actual 2019 Mavyret sales is 3-4%.